Average Co-Inventor Count = 6.31
ph-index = 10
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (18 from 2,405 patents)
2. Schering Corporation (7 from 1,829 patents)
3. Intervet Inc. (2 from 245 patents)
4. Ra Pharmaceuticals, Inc. (2 from 28 patents)
5. Intervet International B.v. (1 from 104 patents)
27 patents:
1. 12012468 - Cyclic polypeptides for PCSK9 inhibition
2. 11530244 - Cyclic polypeptides for PCSK9 inhibition
3. 11161819 - Substituted tetrahydroisoquinoline compounds useful as GPR120 agonists
4. 9687494 - Iminothiadiazine dioxide compounds as BACE inhibitors, compositions, and their use
5. 9499502 - 5-substituted iminothiazines and their mono- and dioxides as BACE inhibitors, compositions, and their use
6. 9475785 - Iminothiadiazine dioxide compounds as BACE inhibitors, compositions and their use
7. 9453034 - C2-azaspiro iminothiazine dioxides as BACE inhibitors, compositions, and their use
8. 9428475 - Iminothiadiazine dioxide compounds as BACE inhibitors, compositions, and their use
9. 9422277 - Tricyclic substituted thiadiazine dioxide compounds as BACE inhibitors, compositions and their use
10. 9416129 - Tricyclic substituted thiadiazine dioxide compounds as BACE inhibitors, compositions and their use
11. 9221839 - C5-C6 oxacyclic-fused thiadiazine dioxide compounds as BACE inhibitors, compositions, and their use
12. 9145426 - Pyrrolidine-fused thiadiazine dioxide compounds as BACE inhibitors, compositions, and their use
13. 9029362 - Iminothiadiazine dioxide compounds as brace inhibitors, compositions, and their use
14. 8940748 - Iminothiadiazine dioxide compounds as BACE inhibitors, compositions, and their use
15. 8735604 - Pyrrolidines as glucagon receptor antagonists, compositions, and methods for their use